SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-023401
Filing Date
2016-04-28
Accepted
2016-04-28 18:45:56
Documents
1
Period of Report
2016-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A - edgar.html 3/A  
1 FORM 3/A - edgar.xml 3/A 2503
  Complete submission text file 0001179110-16-023401.txt   4072
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
STEIN EVAN A. (Reporting) CIK: 0001620461 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36500 | Film No.: 161601808